Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T12:05:37.701Z Has data issue: false hasContentIssue false
  • English
  • Français

Surgical Site Infection (SSI) Rates Among Patients Who Underwent Mastectomy After the Introduction of SSI Prevention Policies

Published online by Cambridge University Press:  21 June 2016

Diana Vilar-Compte ,
Rodrigo Roldán-Marín ,
Carlos Robles-Vidal  and
Patricia Volkow
Diana Vilar-Compte*
Affiliation:
Department of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City, Mexico
Rodrigo Roldán-Marín
Affiliation:
Department of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City, Mexico Dermatology Department, Hospital General “Dr. Manuel Gea Gonzalez, ” Mexico City, Mexico
Carlos Robles-Vidal
Affiliation:
Breast Tumor Department, Instituto Nacional de Cancerología, Mexico City, Mexico
Patricia Volkow
Affiliation:
Department of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City, Mexico
*
Departamento de Infectologia, Instituto Nacional de Cancerologia (INCan), Av. San Fernando 22, Col. Seccion XVI, Mexico City, 14080, Mexico, (diana_vilar@yahoo.com.mx)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To describe the results of an intervention program to reduce the rate of surgical site infection (SSI) in the breast tumor department of a referral teaching hospital for patients with cancer.

Methods.

Preventive measures introduced in the Breast Tumor Department of the study hospital included the following: starting in July 2000, use of sterile technique for wound care; starting in 2001, use of closed antireflux silicone evacuation systems, use of perioperative antimicrobial prophylaxis, provision of feedback to surgeons, and remodeling of the ambulatory wound care clinic. We conducted surveillance of all patients who underwent mastectomy between February 1 and December 31, 2001, and the SSI rate was calculated. A case-control analysis was performed for risk factors known to be associated with SSI. Results were compared with the data from 2000.

Results.

The study included data on 385 surgeries. SSIs were registered in 52 (13.7%) of these 385, which was a rate 58.6% less than the 2000 infection rate (33.1%). Risk factors associated with SSI included concomitant chemotherapy and radiation therapy (OR, 3.6 [95% confidence interval {CI}, 1.9-7.1]), surgery performed during an evening shift (OR, 1.9 [95% CI, 1.1-3.6]), and insertion of a second drainage tube during the late postoperative period (OR, 2.8 [95% CI, 1.4-5.7]). The mean number (± SD) of postoperative visits to the outpatient wound care clinic was reduced from 11.6 ± 7.1 in 2000 to 9.2 ± 4.4 in 2001 (P< .001, Student's t test). The mean number of days that the evacuation systems were used was reduced from 19.0 to 16.0 days (P =.001, Student's t test).

Conclusions.

Continuous wound surveillance, along with feedback to surgeons, use of closed antireflux evacuation systems, and standardized practices in wound and drainage-tube care, decreased by 58.6% the rate of SSI in a breast surgical department with high rates of infection.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 8 , August 2006 , pp. 829 - 834
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Whitehouse, JD, Friedman, ND, Kirkland, KB, Richardson, WJ, Sexton, DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23:183–189.CrossRefGoogle Scholar
2. Melling, AC, Ali, B, Scott, EM, Leaper, DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet 2001; 358:876–880.CrossRefGoogle ScholarPubMed
3. Reilly, J, Twaddle, S, McIntosh, J, Kean, L. An economic analysis of surgical wound infection. J Hosp Infect 2001; 49:245–249.CrossRefGoogle ScholarPubMed
4. Letrilliart, L, Guiguet, M, Hanslik, T, Flahault, A. Postdischarge nosocomial infections in primary care. Infect Control Hosp Epidemiol 2001; 22:493–498.CrossRefGoogle ScholarPubMed
5. Vilar-Compte, D, Mohar, A, Sandoval, S, De la Rosa, M, Gordillo, P, Volkow, P. Surgical site infections at the National Cancer Institute in Mexico: a case-control study. Am J Infect Control 2000; 28:14–20.CrossRefGoogle ScholarPubMed
6. Cruse, PJE, Foord, R. The epidemiology of wound infection. Surg Clin North Am 1980; 60:27–40.CrossRefGoogle ScholarPubMed
7. Gaynes, RP, Culver, DH, Horan, TC, Edwards, JR, Richards, C, Tolson, JS, and the National Nosocomial Infections Surveillance System. Surgical site infection (SSI) rates in the United States, 1992-1998: the national nosocomial infections surveillance system basic SSI risk index. Clin Infect Dis 2001; 33(Suppl 2):S69–S76.CrossRefGoogle ScholarPubMed
8. Barber, GR, Miransky, J, Brown, AE, et al. Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg 1995; 130: 1042–1047.CrossRefGoogle Scholar
9. Broadwater, JR, Edwards, MJ, Craig, K, Hortobagyi, GN, Ames, FC, Balch, CM. Mastectomy following preoperative chemotherapy: strict operative criteria control operative morbidity. Ann Surg 1991; 213:126–129.CrossRefGoogle ScholarPubMed
10. Canavase, G, Catturich, A, Vecchio, C, et al. Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer: results of a prospective, controlled randomized clinical trial. Eur J Surg Oncol 1997; 23:10–12.CrossRefGoogle Scholar
11. Furey, PC, Macgillivray, DC, Macgillivray, DC, Castiglione, CL, Allen, L. Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer. J Surg Oncol 1994; 55:194–197.CrossRefGoogle ScholarPubMed
12. Vilar-Compte, D, Jacquemin, B, Robles-Vidal, C, Volkow, P. Surgical site infections in breast surgery: case-control study. World J Sur 2004; 28: 242–246.CrossRefGoogle ScholarPubMed
13. Vilar-Compte, D, Jacquemin, B, Díaz-González, A, Velásquez, C, Volkow, P. Brote por Pseudomonas aeruginosa, en el área de atención ambulatoria de heridas quirúrgicas en pacinetes postmastectomizadas. Salu Publica Mex 2003; 45:371–378.CrossRefGoogle Scholar
14. Horan, TC, Gaynes, RP, Martone, WJ, William, RJ, Emori, TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606–608.CrossRefGoogle ScholarPubMed
15. Martone, WJ, Nichols, RL. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 2001;33(Suppl 2):S67–S68.CrossRefGoogle Scholar
16. Perl, TM. Surveillance, reporting, and the use of computers. In: Wenzel, RP, ed. Prevention and Control of Nosocomial Infections. Philadelphia: Williams and Wilkins; 1997:127–161.Google Scholar
17. Platt, R, Yokoe, DS, Sands, KE, CDC Eastern Massachusetts Preventive Epicenter Investigators. Automated methods for surveillance of surgical site infections. Emerg Infect Dis 2001; 7:212–216.CrossRefGoogle ScholarPubMed
18. Lee, JT. Wound infection surveillance. Infect Dis Clin North Am 1992; 6: 643–656.CrossRefGoogle ScholarPubMed
19. Sauter, ER, Eisenberg, BL, Hoffman, JP, et al. Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World J Sur 1993; 17:237–242.CrossRefGoogle ScholarPubMed
20. Badr El Din, A, Coibion, M, Nogaret, JM, et al. Local postoperative morbidity following pre-operative irradiation in locally advanced breast cancer. Eur J Surg Oncol 1989; 15:486–489.Google ScholarPubMed
21. Borer, A, Gilad, J, Meydan, N, et al. Impact of active monitoring of infection control practices on deep sternal infection after open-heart surgery. Ann Thorac Surg 2001; 72:515–520.CrossRefGoogle ScholarPubMed
22. Reilly, J. Changing surgical practice through feedback of performance data. J Advanced Nursing 2002; 38:607–614.CrossRefGoogle ScholarPubMed
23. Schneeberger, PM, Smits, MH, Zick, REF, Wille, JC. Surveillance as a starting point to reduce surgical-site infection rates in elective orthopedic surgery. J Hosp Infect 2002; 51:179–184.CrossRefGoogle Scholar
24. Mangram, AJ, Horan, TC, Pearson, MC, Silver, LC, Jarvis, WR. Guideline for the prevention of surgical site infection. Infect Control Hosp Epidemiol 1999;20:250–278.CrossRefGoogle ScholarPubMed
25. Stocks, G, Janssen, HF. Infection in patients after implantation of an orthopedic device. ASAIO Journal 2000; 46:S41–S46.CrossRefGoogle ScholarPubMed
26. Burke, JP. Maximizing appropriate surgical antibiotic prophylaxis: an update from LDS hospital. Clin Infect Dis 2001;33(Suppl 2):S78–S83.CrossRefGoogle ScholarPubMed
27. Condon, RE, Schutle, WJ, Malagoni, MA, Anderson-Teschendorf, MJ. Effectiveness of surgical wound surveillance program. Arch Surg 1983; 118: 303–307.CrossRefGoogle ScholarPubMed
28. Lau, WY, Fan, ST, Chu, KW, Yip, WC, Yuen, WC, Wong, KK. Influence of surgeons' experience on postoperative sepsis. Am J Surg 1988; 155:322–326.CrossRefGoogle ScholarPubMed